BARRINGTON LABORATORIES INC
10QSB, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: BARRINGTON LABORATORIES INC, 10QSB, 2000-08-14
Next: HENDLEY & CO INC, 13F-HR, 2000-08-14



<TABLE> <S> <C>


        <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
BALANCE SHEET, THE STATEMENT OF OPERATIONS, AND THE STATEMENT OF CASH FLOWS
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          19,799
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                19,799
<PP&E>                                          11,716
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  31,515
<CURRENT-LIABILITIES>                              360
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         3,751
<OTHER-SE>                                      27,404
<TOTAL-LIABILITY-AND-EQUITY>                    31,515
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                     1,429
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (10,033)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (1,429)
<EPS-BASIC>                                    (0.00)
<EPS-DILUTED>                                    (0.00)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission